ARGX argenx SE
$959.49
argenx SE (ARGX) is confirmed to report earnings on October 22, 2026, before the market open. The consensus earnings estimate is $7.62 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.2% since its last earnings release on July 23, 2026.
argenx SE Beat Expectations
Thursday, July 23, 2026 · 1:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 22
Thursday · 1:00 AM ET
Earnings Whisper
-
vs $7.62
Rev est $1.66B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$953.67
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About argenx SE
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Sector
Healthcare
Industry
Biotechnology
Held By 10 ETFs, by dollar flow
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- BBH VanEck Biotech ETF
- BBH VanEck Biotech ETF
- FEZ SPDR EURO STOXX 50 ETF
- FEZ SPDR EURO STOXX 50 ETF
- IBRN iShares Neuroscience and Healthcare ETF
- IBRN iShares Neuroscience and Healthcare ETF
Charts powered in part by Lightweight Charts™ by TradingView.